PM 104
Alternative Names: Polyoxometalate 104Latest Information Update: 22 Nov 2007
At a glance
- Originator Nonindustrial source
- Developer Nonindustrial source; Terumo
- Class Antivirals; Organometallic compounds
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 14 Jul 1998 No-Development-Reported for HIV infections treatment in Japan (Unknown route)
- 01 Nov 1994 Preclinical development for HIV infections treatment in Japan (Unknown route)